Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 25 | HRTX Heron Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 17,950 | 0.00 | 69,777 |
31 Jan 25 | HRTX Heron Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.7 | 35,900 | 61.03 k | 35,900 |
30 Jan 25 | HRTX Heron Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 17,950 | 0.00 | 69,777 |
30 Jan 25 | HRTX Heron Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.73 | 35,900 | 62.11 k | 35,900 |
16 Sep 24 | ALIM Alimera Sciences | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 4,178,725 | 0.00 | 0 |
16 Sep 24 | ALIM Alimera Sciences | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 9,429,808 | 0.00 | 0 |
16 Sep 24 | ALIM Alimera Sciences | Warrants Common Stock | Sale back to company | Dispose D | Yes | No | 2.1 | 800,000 | 1.68 mm | 0 |
16 Sep 24 | ALIM Alimera Sciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.99 | 50,000 | 149.50 k | 0 |
16 Sep 24 | ALIM Alimera Sciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.85 | 1,825 | 3.38 k | 0 |
8 Feb 24 | JSPR Jasper Therapeutics | Common Stock, par value $0.0001 per share | Buy | Acquire P | Yes | No | 12.95 | 350,000 | 4.53 mm | 1,188,500 |